Related references
Note: Only part of the references are listed.Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies to nanocarriers
Johanna Simon et al.
NANO TODAY (2022)
Brush Conformation of Polyethylene Glycol Determines the Stealth Effect of Nanocarriers in the Low Protein Adsorption Regime
Mengyi Li et al.
NANO LETTERS (2021)
From lipids to lipid nanoparticles to mRNA vaccines
Christine Horejs
NATURE REVIEWS MATERIALS (2021)
Inorganic nanomaterials with rapid clearance for biomedical applications
Xianwen Wang et al.
CHEMICAL SOCIETY REVIEWS (2021)
The conjugation strategy affects antibody orientation and targeting properties of nanocarriers
Maximilian Brueckner et al.
NANOSCALE (2021)
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
Joao Calmeiro et al.
PHARMACEUTICS (2020)
Stealth Coating of Nanoparticles in Drug-Delivery Systems
See Yee Fam et al.
NANOMATERIALS (2020)
Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
Riccardo Dolcetti et al.
FRONTIERS IN IMMUNOLOGY (2020)
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Gergely Tibor Kozma et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
Alberto Juan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures
Hongliang He et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Nanoparticles in the clinic: An update
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Role of Linker Length and Antigen Density in Nanoparticle Peptide Vaccine
Chintan H. Kapadia et al.
ACS OMEGA (2019)
The Transferability from Animal Models to Humans: Challenges Regarding Aggregation and Protein Corona Formation of Nanoparticles
Laura K. Mueller et al.
BIOMACROMOLECULES (2018)
Debugging Nano-Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies
Morteza Mahmoudi
TRENDS IN BIOTECHNOLOGY (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulation
David Passlick et al.
JOURNAL OF CONTROLLED RELEASE (2018)
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Jung Soo Suk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10
Matthias Bros et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Bankruptcy of nanomedicine firm worries drug developers
Heidi Ledford
NATURE (2016)
Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers
Susanne Schoettler et al.
NATURE NANOTECHNOLOGY (2016)
Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future
Anna N. Ilinskaya et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells
Giulio Caracciolo et al.
LANGMUIR (2015)
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study
Luis J. Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A Systematic Analysis of Peptide Linker Length and Liposomal Polyethylene Glycol Coating on Cellular Uptake of Peptide-Targeted Liposomes
Jared F. Stefanick et al.
ACS NANO (2013)
Optimizing the Properties of the Protein Corona Surrounding Nanoparticles for Tuning Payload Release
Anna Cifuentes-Rius et al.
ACS NANO (2013)
The Smart Targeting of Nanoparticles
Adam Friedman et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
Anna Salvati et al.
NATURE NANOTECHNOLOGY (2013)
Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
Stefano Salmaso et al.
JOURNAL OF DRUG DELIVERY (2013)
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Carl D. Walkey et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis
Stefan Tenzer et al.
ACS NANO (2011)
The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells
Luis J. Cruz et al.
BIOMATERIALS (2011)
Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting
Shyh-Dar Li et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
Parameters influencing the stealthiness of colloidal drug delivery systems
Arnaud Vonarbourg et al.
BIOMATERIALS (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Absolute quantification of proteins by LCMSE - A virtue of parallel MS acquisition
JC Silva et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Rapid monoclonal antibody generation via dendritic cell targeting in vivo
JD Berry et al.
HYBRIDOMA AND HYBRIDOMICS (2003)
Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells
C Ammon et al.
IMMUNOLOGY (2000)
Share Paper
